Differential effects of hydroxyurea and zileuton on interleukin-13 secretion by activated murine spleen cells: Implication on the expression of vascular cell adhesion molecule-1 and vasoocclusion in sickle cell anemia

Cytokine

Volumn 30, Issue 5, 2005, Pages 213-218

  Kuvibidila, Solo ^a   Baliga, B Surendra ^b   Gardner, Renee ^a   Yu, Lolie ^a   Warrier, Raj ^a   Velez, Maria ^a   Ode, David ^a   Haynes, Johnson ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Hydroxyurea; Interleukin 13; Sickle cell anemia; Vasoocclusion; VCAM 1; Zileuton

Indexed keywords

CONCANAVALIN A; HYDROXYUREA; INTERLEUKIN 13; MITOGENIC AGENT; VASCULAR CELL ADHESION MOLECULE 1; ZILEUTON;

ANIMAL CELL; ARTICLE; BLOOD VESSEL OCCLUSION; CELL ACTIVATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CYTOKINE RELEASE; FEMALE; GENE ACTIVATION; INCUBATION TIME; INHIBITION KINETICS; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SICKLE CELL ANEMIA; SPLEEN CELL;

ANEMIA, SICKLE CELL; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; FEMALE; HYDROXYUREA; INTERLEUKIN-13; LYMPHOCYTES; MICE; MICE, INBRED C57BL; SPLEEN; VASCULAR CELL ADHESION MOLECULE-1; VASOCONSTRICTION;

MURINAE;

EID: 20144385008     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2005.01.010     Document Type: Article

References (30)

1. S. Ying, Q. Meng, L.T. Barata, D.S. Robinson, S.R. Durham, and B. Kay Association between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects J Immunol 158 1997 5050 5057
2. B.S. Bochner, D.A. Klunk, S.A. Sterbinsky, R.L. Coffman, and R.P. Schleimer IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells J Immunol 154 1995 799 803
3. A.J. Duits, R.C. Pieters, A.W. Saleh, and E. van Rosemalen Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis Clin Immunol Immunopathol 81 1996 96 98
4. B.N.Y. Setty, and M.J. Stuart Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease Blood 88 1996 2311 2320
5. M.J. Stuart, and B.N.Y. Setty Sickle cell acute chest syndrome: pathogenesis and rationale for treatment Blood 94 5 1999 1555 1560
6. B.E. Gee, and O.S. Platt Sickle erythrocytes adhere to VCAM-1 Blood 85 1995 268 274
7. M.H. Steinberg, O. Barton, C.H. Pegelow, S.K. Ballas, A. Kutlar, and R. Bellevue Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia. Risks and benefits up to 9 years on treatment JAMA 289 2003 1645 1651
8. A. Ferster, P. Tahriri, C. Vermylen, G. Sturbois, F. Corazza, and P. Fondu Five years of experience with hydroxyurea in children and young adults with sickle cell disease Blood 97 2001 3628 3632
9. M. de Montalembert, M. Belloy, F. Bernaudin, F. Gouraud, R. Capdeville, and R. Mardini Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease J Pediatr Hematol Oncol 19 4 1997 313 318
10. J.P. Scott, C.A. Hillery, E.R. Brown, V. Miesiewicz, and R.J. Labotka Hydroxyurea therapy in children severely affected with sickle cell disease J Pediatr 128 6 1996 820 828
11. J. Haynes, S.B. Baliga, B. Obiako, S. Ofori-Acquah, and B. Pace Zileuton induces hemoglobin F synthesis in erythroid progenitors: role of l-arginine-nitric oxide signaling pathway Blood 103 10 2004 3945 3950
12. J. Haynes, and B. Obiako Activated polymorphonuclear cells increase sickle red blood cell retention in lung: role of phospholpids Am J Physiol Heart Circ Physiol 282 2002 H122 H130
13. C.R. Chitambar, and J.P. Wereley Effect of hydroxyurea on cellular iron metabolism in human leukemic CCRF-CEM cells: changes in iron uptake and the regulation of transferrin receptor and ferritin gene expression following inhibition of DNA synthesis Cancer Res 55 1995 4361 4366
14. F. Nagase, T. Abo, K. Hiramatsu, S. Suzuki, J. Du, and I. Nakashima Induction of apoptosis and tyrosine phosphorylation of cellular proteins in T cells and non-T cells by stimulation with concanavalin A. Microbiol Immunol 42 1998 567 574
15. A.K. Abbas, A.H. Lichtman, and J.S. Pobeer T lymphocyte antigen recognition and activation A.K. Abbas A.H. Lichtman J.S. Pober Cellular and molecular immunology 3rd ed. 1997 WB Saunders Company Philadelphia 138 170
16. M.G. Malaise, P. Franchimont, and P.R. Mahieu The ability of normal human monocytes to phagocytose IgG-coated red blood cells is related to the number of accessible galactosyl and mannosyl residues in the Fc domain of the anti-red blood cell IgG antibody molecules J Immunol Methods 119 1989 231 239
17. D.H. Cribbs, V.W. Kreng, A.J. Anderson, and C.W. Cotman Cross-linking of concanavalin A receptor on cortical neurons induces programmed cell death Neuroscience 75 1 1996 173 185
18. J.G. Punnomen, B.G. Cocks, A.N.J. McKenzie, G. Menon, G. Zurawski, and R.D. Malefyt IL-13 induces IL4-independent IgG4 and IgE synthesis and CD23 expression by human B cells Proc Natl Acad Sci U S A 90 1993 3730 3734
19. G.W. Sullivan, D.D. Lee, W.G. Ross, J.A. DiVietro, C.M. Lappas, and M.B. Lawrence Activation of A2A adenosine receptors inhibits expression of alpha-4/beta-1 integrin (very late antigen-4) on stimulated human neutrophils J Leukoc Biol 75 2004 127 134
20. S.C. Taylor, S.J. Shacks, and Z. Qu In vivo production of type-1 cytokines in healthy sickle cell disease patients J Natl Med Assoc 91 1999 619 624
21. H. Croisat, and R.L. Nagel Circulating cytokines response and the level of erythropoiesis in sickle cell anemia Am J Hematol 60 1999 105 115
22. E. Israel, J. Cohn, L. Dube, J.M. Drazen For the Zileuton Clinical Trial Group Effect of treatment with zileuton, a 5-lipoxygenase inhibitor in patients with asthma. A randomized controlled trial JAMA 275 1996 931 936
23. G.W. Carter, P.R. Young, D.H. Albert, J. Bouska, R. Dyer, and R.L. Bell 5-Lipoxygenase inhibitory activity of zileuton J Pharmacol Exp Ther 256 3 1991 929 937
24. M.C. Liu, L.M. Dube, J. Lancaster The Zileuton Study Group Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial J Allergy Clin Immunol 98 1996 859 871
25. J.A.B. Chies, and N.B. Nardi Sickle cell disease: a chronic inflammatory condition Med Hypotheses 57 1 2001 46 50
26. O.S. Platt Sickle cell anemia as an inflammatory disease J Clin Invest 106 2000 337 338
27. A. Pathare, S.A. Kindi, S. Daar, and D. Dennison Cytokines in sickle cell disease Hematology 8 5 2003 329 337
28. S. Kuvibidila, R. Gardner, D. Ode, L. Yu, G. Kane, and R.P. Warrier Tumor necrosis factor-alpha in children with sickle cell disease in stable condition J Natl Med Assoc 89 1997 609 615
29. S.R. Kuvibidila, and C. Porretta Iron deficiency and in vitro iron chelation reduce the expression of cluster of differentiation (CD)28 but not CD3 receptors on murine thymocytes and spleen cells Br J Nutr 90 2003 179 189
30. H.B. Munro Differences among group means: oneway analysis of variance H.B. Munro E.B. Page Statistical methods for health care research 2nd ed. 1993 JP Lippincott Company Philadelphia 99 128